Related Experiment Video
Updated: May 25, 2026

10:43
High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
Published on: November 5, 2016
Development of bacterially resistant polyurethane for coating medical devices
Nima Roohpour1, Alireza Moshaverinia, Jaroslaw M Wasikiewicz
1School of Engineering and Materials Science, IRC in Biomedical Materials, Queen Mary University, London, UK. n.roohpour@qmul.ac.uk
Biomedical Materials (Bristol, England)
|January 31, 2012
Summary
Researchers developed a novel bacterially resistant polymer by incorporating silver lactate and silver sulfadiazine into polyether-urethane. This modification maintains the material
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Medical Device Technology
Background:
- Polyurethanes are widely used in medical devices for their mechanical properties and biocompatibility.
- However, polyurethanes are susceptible to microbial biofilm formation, posing a risk in medical applications.
- Developing antimicrobial medical materials is crucial for preventing device-associated infections.
Purpose of the Study:
- To create a bacterially resistant polyether-urethane polymer.
- To achieve antimicrobial properties without compromising the material's mechanical integrity.
- To covalently incorporate silver ions into the polymer structure.
Main Methods:
- Polyether-urethane was end-capped with silver lactate and silver sulfadiazine.
- Silver ions were covalently incorporated during polymer chain extension.
- Structural characterization included light scattering, electron microscopy, NMR, FTIR, and Raman spectroscopy.
- Mechanical properties, hydrophilicity, in vitro stability, and antibacterial action were evaluated.
Main Results:
- Successful covalent incorporation of silver lactate and silver sulfadiazine into the polyether-urethane structure.
- The modified polymer retained desirable mechanical properties.
- The functionalized polymer demonstrated acceptable resistance to bacterial growth.
- Structural integrity and biocompatibility were maintained.
Conclusions:
- End-capping polyether-urethane with silver salts is an effective strategy for creating bacterially resistant biomaterials.
- This approach offers a promising solution for reducing microbial contamination on medical devices.
- The developed material maintains essential mechanical properties for medical applications.
Related Concept Videos
Bacterial Signaling
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
